Worldwide Clinical Trials, a global contract research organization based in North Carolina, recently faced a significant data breach. On November 13, 2023, the company’s IT staff identified suspicious activity within their network, prompting immediate action to secure their systems. A thorough investigation, assisted by an external cybersecurity firm, revealed that an unauthorized actor accessed sensitive personal identifiable information between November 11 and November 13, 2023. The compromised data includes names and Social Security numbers of current and former employees. On May 8, 2024, Worldwide Clinical Trials began notifying those affected by the breach.
The organization has taken several steps to address the situation and support the individuals impacted. They have arranged for a complimentary one-year membership to Experian’s IdentityWorks credit monitoring service, which helps detect potential misuse of personal information and provides identity protection services. Enrolling in IdentityWorks will not affect credit scores, offering peace of mind and immediate assistance for those concerned about identity theft.
Worldwide Clinical Trials is committed to preventing such incidents in the future by implementing additional security measures and safeguards. They take this breach seriously and are dedicated to maintaining the trust and security of their clients and employees. Anyone with questions about the incident or who needs further assistance can contact the company’s dedicated support line available Monday through Friday.
By providing timely notifications and offering robust identity protection services, Worldwide Clinical Trials aims to mitigate the impact of the breach and reassure those affected that their security is a top priority. The organization’s proactive response underscores their dedication to addressing cybersecurity threats and protecting sensitive information.
